Skip to content

Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus

Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00985361
Enrollment
37
Registered
2009-09-28
Start date
2009-10-31
Completion date
2010-03-31
Last updated
2010-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Brief summary

The purpose of this study is to determine if daily supplementation with 2000 International Units of Vitamin D will improve hemoglobin A1c in uncontrolled type 2 diabetics.

Detailed description

Vitamin D is typically understood to support musculoskeletal health when administered concomitantly with calcium. A number of recent studies suggest, however, that this important nutrient may play a significant role in many pathophysiological processes, including diabetes mellitus. With the prevalence of diabetes mellitus ever increasing, novel mechanisms for controlling blood glucose and hemoglobin A1c are being sought to help prevent the costly and debilitating complications of this chronic disease.

Interventions

DIETARY_SUPPLEMENTVitamin D3 2000 international units daily

Vitamin D3 2000 international unit tablets once daily for 3 months

DIETARY_SUPPLEMENTVitamin C 500mg daily

Vitamin C 500mg tablets once daily for 3 months

Sponsors

ProMedica Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 diabetes mellitus * Hemoglobin A1c \>7% measured in the 3 months prior to randomization * Age 21 to 75 years

Exclusion criteria

* Renal insufficiency (defined as CrCl \<30mL/min) * Gestational diabetes * Malabsorption syndrome * Patients taking vitamin D supplements at doses \>400 international units daily

Design outcomes

Primary

MeasureTime frame
Hemoglobin A1c3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026